Frisco, Texas, February 26, 2013 – OxySure® Systems, Inc. (OTCBB: OXYS) (“OxySure,” or the “Company”), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology is excited to announce that in excess of 2,000 saves have been estimated in connection with the use of its flagship product, the OxySure Model 615 emergency oxygen device.
A ‘save’ is regarded as an incident during which Model 615 was used to assist someone in a medical emergency or other distress situation. Examples of such situations vary widely, and can include serious incidents such as cardiac arrest (in which OxySure is used post-resuscitation), as well as events such as asthma attacks, COPD exacerbations, allergy attacks, heat exhaustion, hypoxia/altitude sickness, migraine attacks, poisoning/overdose, diabetic emergencies, smoke inhalation, seizures, chest pain, fainting, dehydration, near drowning, hyperthermia, injury with trauma, and the treatment of shock. The standard of care in most medical emergencies is for first responders to provide supplemental oxygen to patients typically immediately upon arrival. OxySure’s Model 615 allows lay rescuers to begin sooner, thereby bridging the gap until professional responders arrive on the scene and can provide more advanced care.
“The OxySure Model 615 enables a loved one, bystander or even the person him/herself to provide oxygen, awaiting the arrival of emergency medical responders,” stated Dr. Vincent Mosesso, Medical Director of pre-hospital care services for the University of Pittsburgh Medical Center (UPMC), and also co-founder and Medical Director of the National Center for Early Defibrillation, now called Sudden Cardiac Arrest Association.
“We are indeed thrilled by the phenomenal usage validation our product has enjoyed in a very short period of time,” stated Julian Ross, CEO of OxySure. “We believe that as our installed base continues to grow the usage will grow significantly, as will the comfort level and awareness of the product by our customers.”
“OxySure is going to increase that golden window of opportunity when things have to be done immediately to ensure survival,” stated Dr. James R. Winn, former CEO of the Federation of State Medical Boards of the United States. See what Dr. Winn and others are saying in a short video clip that can be found here: http://www.oxysure.com/aed/index.php/video-listings
About OxySure Systems, Inc.
OxySure Systems, Inc. is a Frisco, Texas-based medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure’s products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other “Immediately Dangerous to Life or Health” (IDLH) environments. www.OxySure.com
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.
Investor Relations Contact(s): Media Contact:
Andrew J. Barwicki, (516) 662-9461 Yves Dezawy, (646) 546-5151
Chris Hagerman, (208) 361-6624